Introduction
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are adult-onset neurodegenerative disorders. While FTD and ALS are, respectively, characterized by progressive degeneration of frontal and temporal lobes or loss of both upper and lower motor neurons, there is clinical and genetic overlap between them (1) . The expansion of the GGGGCC hexanucleotide repeat in the non-coding region of the Chromosome 9 open-reading frame 72 (C9orf72) gene is the most common genetic cause of glycine-proline ( poly-GP) and glycine-arginine ( poly-GR) from the sense transcripts, and glycine-proline ( poly-GP), proline-arginine ( poly-PR) and proline-alanine ( poly-PA) from the antisense transcripts. It has been shown that poly-PR is toxic to NSC34 cells and mouse motor neurons and poly-PR and poly-GR are toxic in a Drosophila model. However, the underlying mechanisms of toxicity caused by poly-PR and poly-GR are not clear (11) (12) (13) . Here, we show that poly-PR and poly-GR inhibit protein translation by binding to the translational complex and ribosomal proteins, leading to neurotoxicity.
Results
To understand the mechanisms of neurotoxicity mediated by C9orf72-derived polypeptides, we synthesized C-terminally hemagglutinin (HA)-tagged 20 repeats of Proline-Arginine dipeptide [ poly-(PR) 20 ], Glycine-Arginine dipeptide [ poly-(GR) 20 ] and Glycine-Alanine dipeptide [ poly-(GA) 20 ], and examined the neurotoxicity in NSC34 cells. Poly-(PR) 20 caused cell death in motor neuronal NSC34 cells (Fig. 1A) . To a lesser extent, poly-(GR) 20 showed neurotoxicity, but poly-(GA) 20 did not (Fig. 1A) . We, next, performed an immunoprecipitation analysis followed by a liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify interacting proteins of poly-(PR) 20 . NSC34 cells were cultured for 5 days in the presence or absence of poly-(PR) 20 , and then their lsyates were immunoprecipitated with anti-HA antibody and subjected to LC-MS/MS. We discovered that multiple RNA-binding proteins were bound to the poly-(PR) 20 . The PANTHER (Protein Annotation Through Evolutionary Relationship) classification system revealed that the most abundant class of interacting proteins was ribosomal proteins ( Fig. 1B) (14) . Translation initiation factors and translation elongation factors were also identified, suggesting that poly-(PR) 20 might interact with proteins involved in protein translation. STRING (Search Tool for the Retrieval of Interacting Genes/proteins) identified three functional clusters involved in: (i) protein translation, (ii) mRNA splicing and (iii) ribosome assembly ( Fig. 1C) (15) .
To validate the results of LC-MS/MS, we perfomed co-immunoprecipitation assays and confirmed that poly-(PR) 20 interacted with heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), eukaryotic elongation factor 1A (eEF1A), eukaryotic initiation factor 3A (eIF3A) and ribosomal protein L7A (RPL7A) ( Fig. 1D ). We also discovered that ALS-causative RNA-binding proteins, including TAR DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS), were co-immunoprecipitated with poly-(PR) 20 (Fig. 1D ). The interactions between poly-(PR) 20 and RNA-binding proteins, such as hnRNPA1, eEF1A, TDP-43 and FUS, were diminished by RNAse treatment, suggesting that these interactions might be mediated by RNA ( Fig. 1D ). To exclude the possibility that the interaction between poly-(PR) 20 and RNA-binding proteins, such as hnRNPA1, TDP-43 and FUS, were artificially formed during cell lysis procedure, we first performed immunocytochemical analysis to show the colocalization of HA-poly-(PR) 20 and hnRNPA1. HA-poly-(PR) 20 mainly localized to cytosol and partially localized to nucleus, and colocalized with hnRNPA1 ( Fig. 1E ). Next we examined subcellular fractionation of NSC34 cells treated with HA peptide or HA-poly-(PR) 20 followed by coimmunoprecipitation with anti-HA antibody using the nuclear fraction. As Figure 1F shows, HA-poly-(PR) 20 interacted with hnRNPA1, TDP-43 and FUS in the nuclear fraction, indicating that the interaction between HA-poly-(PR) 20 and RNA-binding proteins including hnRNPA1, TDP-43 and FUS were phyisiologically, but not artificially formed. Consistent with these findings, immunostaining of brain sections from patients with C9orf72 ALS showed that poly-GR was colocalized with hnRNPA1 ( Fig. 2 ).
Poly-(PR) 20 peptide and poly-(GR) 20 
inhibit protein translation
Most of the poly-(PR) 20 -interacting proteins were involved in protein translation, raising the possibility that poly-(PR) 20 may affect protein translation. To test this idea, we perfomed an in vitro translation (IVT) assay using HeLa cell lysates and cDNA encoding green fluorescent protein (GFP) as a reporter. Real-time monitoring of GFP fluorescence and immunoblot analysis showed that poly-(PR) 20 inhibited protein translation in vitro in a dose-dependent manner ( Fig. 3A -C). To distinguish whether poly-(PR) 20 inhibits the expression of GFP protein at the transcriptional level or translational level, we performed IVT using synthesized mRNA of GFP, and poly-(PR) 20 inhibited GFP translation from GFP mRNA ( Fig. 3D -F), indicating that poly-(PR) 20 inhibits protein translation. To confirm the inhibitory effect of C9orf72 dipeptides on translation in vivo, we next treated NSC34 cells with poly-(PR) 20 , poly-(GR) 20 or poly-(GA) 20 , and then tested the protein translation using a puromycin-based labeling of newly synthesized protein method called SUnSET (16) . Poly-(PR) 20 and poly-(GR) 20 , but not poly-(GA) 20 , inhibited general protein translation in a dose-dependent manner ( Fig. 3G-I) . We also confirmed that poly-(PR) 20 suppressed the translation of proteins in mouse primary astrocytes ( Fig. 3J ).
It has been reported that quantitative changes or phosphorylation levels of eukaryotic initiation factors (eIFs) control protein translation (17) (18) (19) (20) (21) . Especially phosphorylation status of eIF2α is a major negative regulator of global protein synthesis under various stress conditions (19) . Thus, we next examined if poly-(PR) 20 mediated translational arrest was caused by quantitative changes or phosphorylation levels of eIFs. Protein expression levels of eIF2α, eIF4A, eIF4A1, eIF4B, eIF4E, eIF4G, eIF4H or phosphorylation levels of eIF4B, eIF4E or eIF4G were not changed by poly-(PR) 20 . The phosphorylation level of eIF2α was slightly suppressed by poly-(PR) 20 . These results suggest that poly-(PR) 20 might inhibit protein translation by a distinct pathway ( Fig. 3K ).
To investigate how poly-(PR) 20 inhibits protein translation, we performed agarose gel electrophoresis of the solution containing poly-(PR) 20 and GFP mRNA used in the IVT assay shown in Figure 3D and E. The amount of soluble GFP mRNA was decreased by poly-(PR) 20 in a dose-dependent manner. Insoluble GFP mRNA accumulated in the loading wells, raising the possibility that poly-(PR) 20 and mRNA formed an insoluble complex ( Fig. 4A ). To test this idea, we mixed yeast total RNA and poly-(PR) 20 , and then measured the optical density of the mixture at 600 nm. The optical densitiy of yeast RNA mixed with poly-(PR) 20 was significantly higher than that of yeast RNA or poly-(PR) 20 alone and this was decreased by RNAse treatment, indicating that RNA and poly-(PR) 20 formed complexes/aggregates ( Fig. 4B and C). To elucidate the nature of these aggregates, we performed immunoblot analysis of poly-(PR) 20 mixed with yeast total RNA. In the presence of RNA, poly-(PR) 20 formed a high-molecular-weight complex 20 peptides mixed with or without yeast total RNA or poly-rA. Each experiment was repeated at least three times and representative images were shown. Asterisks indicate a significant difference analyzed by one-way ANOVA followed by Dunnett's test (**P < 0.01 and *P < 0.05).
( Fig. 4D ). Dithiobis (succinimidyl propionate)-mediated crosslinking assay revealed that RNA enhanced the oligomerlization of poly-(PR) 20 in a dose-dependent manner (Fig. 4E) .
To test if poly-(PR) 20 has selective affinity for a specific ribonucleotide, we examined the effects of four homopolymeric ribonucleotides; poly-adenylic acid ( poly-rA), poly-guanylic acid ( poly-rG), poly citidylic acid ( poly-rC) and poly-uridylic acid ( poly-rU) on the aggregate formation. All homopolymeric ribonucleotides showed similar effects on the aggregate formation of poly-(PR) 20 (Figs 4E and 5A ). We also examined the RNA-mediated aggregate formation of poly-(GR) 20 and poly-(GA) 20 . Similar to poly-(PR) 20 , RNA induced the aggregate formation of poly-(GR) 20 (Fig. 5B ). Due to the strong hydrophobicity as reported previously, poly-(GA) 20 formed high-molecular-weight aggregates without RNA and accumulated in the stacking gel (22) . Thus, we could not examine the effect of RNA on the aggregate formation of poly-(GA) 20 (Fig. 5B ). Electron microscopic images revealed that RNA directely interacted with poly-(PR) 20 and enhanced its aggregation ( Fig. 4F ). These results suggest that RNA may be a possible seed for the poly-PR aggregates seen in patients with c9FTD/ALS.
Proline-Arginine (PR) dipeptides consist of a hydrophobic amino acid (P) and a hydrophilic amino acid (R), and can be dissolved in water due to the poloarity of R (>1 m). However, the dipeptide products of C9orf72 including poly-PR and poly-GR have been shown to deposit in the cytosol of motor neurons as aggegates ( Fig. 2 ) (9) and poly-(PR) 20 formed a water-insoluble complex with RNA shown in Figure 4B . Hydrophobicity of misfolded protein increases its recognition by molecular chaperones, such as heat shock protein 70 (HSP70) and glucose regulated protein 78 (23, 24) and the protein aggregates consisting of misfolded proteins and molecular chaperones are frequently observed in the affected tissues of neurodegenerative disorders including ALS (25) . These considerations prompted us to test if poly-(PR) 20 -RNA aggregates are recognized by HSP70 as misfolded proteins. Co-immunoprecipitation analysis indicated that recombinant HSP70 preferentially interacted with poly-(PR) 20 in the presense of RNA and poly-rA, suggesting that RNA enhanced hydrophobicity of the poly-(PR) 20 peptide and poly-(PR) 20 -RNA aggregates were recognized as misfolded proteins in vitro (Fig. 4G) .
To investgate whether poly-(PR) 20 interacts with endogenous RNA in NSC34 cells, we performed an RNA immunoprecipitation assay (RIP). The RIP assay using the lysates from NSC34 cells cultured with HA peptide or poly-(PR) 20 revealed that poly-(PR) 20 interacted with RNA in NSC34 cells ( Fig. 6A and B) . Furthermore, poly-(GR) 20 , but not poly-(GA) 20 , interacted with RNA, suggesting that the inhibition of protein translation by the C9orf72 dipeptides is mediated by their interaction with RNA ( Fig. 7) .
It has been reported that aberrant splicing of specific genes, including RAN guanosine triphosphatase (RAN GTPase), nascent polypeptide-associated complex subunit alpha (NACA), growth arrest and DNA damage-inducible 45A (GADD45A) and excitatory amino acid transporter 2 (EAAT2) caused by poly-GR and poly-PR dipeptides from C9orf72 gene contributes to the toxicity in human astrocytes (12) . We, therefore, examined whether poly-(PR) 20 interacted with endogenous mRNA of these genes and contributed to cell death in NSC34 cells. The RIP assay followed by reverse transcription-polymerase chain reaction (PCR) confirmed that poly-(PR) 20 interacted with mRNA of RAN GTPase, NACA, GADD45A and EAAT2 (Fig. 6C ). However, we did not observe the alteration of splicing of these mRNA in NSC34 cells (Supplementrary Material, Fig. S1 ).
Our results shown in Figure 3K suggest that impaired protein translation by poly-(PR) 20 may be independent of quantitative changes or phosphorylation levels of translation factors. Poly- (PR) 20 peptide showed high affinity to RNA and directly formed hydrophobic complexes in the experiments shown in Figure 4 . These results raised the possibility that poly-(PR) 20 blocks the access of translation factors to mRNA. To test this idea, mRNA complexes were subjected to pulldown by oligo-dT followed by immunoblot analysis (25) . We found that poly-(PR) 20 blocked the access of eIF4E and eIF4G to mRNA (Fig. 6D ). eIF4E and eIF4G are known to directly interact with mRNA and are essential for the initiation of translation (26) . Collectively, our results indicate poly-(PR) 20 makes complexes with mRNA and prevents the access of translation factors, leading to impaired protein translation.
Discussion
Since the establishment of disease concept of ALS and FTD, clinicians and geneticists have compiled the genetic information of familial cases, accelerating the research to understand the pathophysiology underlying both familial and sporadic cases. The discovery of C9orf72 is a milestone of those studies, which occupies 40% of familial and 10% of sporadic case of ALS, as well as significant population of FTD. Despite its importance, the mechanism how the expansion of GGGGCC hexanucleotide repeat in the non-coding region causes the disease remains not clear. There are several models explaining the neurotoxicity mediated by the expansion of GGGGCC hexanucleotide repeat in C9orf72 at different levels. At the DNA level, expanded DNA-mediated toxicity caused by DNA-RNA G-quadruplexes formation induces nuclear stress and cell death (27) . At the RNA level, it has been shown that RNA-mediated toxicity is mediated by toxic RNA foci formation (7, 8) and RNA-G quadruplexes formation (28) . At the protein level, repetitive GGGGCC sequence potentially triggers unusual protein translation mechanism called repeat-associated non-ATG (RAN) translation, leading to cell death. In the current study, we focused on the toxicity induced at the protein level because recent studies showed that the dipeptide products from C9orf72, which are detected in C9-FTD/ALS cerebrospinal fluid (10), cause cell death in vitro and in a Drosophila model (11, 12) . In this study, we showed that RAN-translated poly-dipeptides, especially poly-PR and poly-GR peptide inhibited protein translation by sequestration of RNA. We discovered that mRNA enhanced aggregate formation of poly-PR and poly-GR peptide, a wellknown pathological hallmark of C9orf72 dipeptides in patients of FTD/ALS, suggesting that the complex formation between poly-PR/GR peptides and RNA plays an important pathological role in FTD/ALS.
Through the LC-MS/MS, we identified more than one hundred novel interactors with poly-PR peptide including ribosomal proteins and translation initiation factors. These interactions were partially dependent on RNA. When analyzed with bioinformatic tools, translation machinery appeared to be a possible target of poly-PR dipeptide, and both in vitro and in vivo translation assays confirmed that poly-PR as well as poly-GR, which were shown to be neurotoxic, inhibited protein translation at the mRNA level. Furthermore, the degrees of the inhibition of protein translation were consistent with the levels of neurotoxicity, as well as their affinity to RNA, suggesting that the impairement of protein translation through interaction with RNA underly the pathogenesis by C9orf72-derived dipeptides.
Dysregulated protein translation plays a role in the development of neurodegenerative diseases. For example, fragile X mental retardation protein has been reported to directly bind to ribosome and inhibit protein translation (29) , and sustained translational repression by eIF2α-P mediates prion neurodegeneration (30) . In the case of C9orf72, overexpression of GGGGCC repeats has been shown to inhibit protein translation (31) . Here, we demonstrated that poly-PR or poly-GR dipeptides, the products of RAN translation from C9orf72, were sufficient to cause inhibition of protein translation. From the observation of LC/MS-MS and coimmunoprecipitation experiments, we hypothesized that there exists direct interaction between poly-PR/GR peptides and RNA. We discovered that RNA enhanced the aggregate formation mediated by both poly-PR or poly-GR peptides. Because poly-PR had high affinity to mRNA itself and made aggregates with RNA, poly-PR prevented the access of translation initiation factorsm such as eIF4E and eIF4G, to mRNA.
How the poly-PR peptide penerates the plasma membrane and sequesters RNA remains to be elucidated, but natural arginine rich peptides such as human immuno-defficiency virus protein trans-activator of transcription peptide are known to destabilize the plasma membrane and penetrate into cytosol, suggesting that poly-PR peptide might destabilize the plasma membrane in a similar manner (32) . We did not observe any significant neurotoxic effect of poly-GA peptide in our experimental system. This might be attributed to the impermeability of poly-GA peptide into the cells. The relationship between cell permeability of dipeptides and cytotoxicity should be further studied in the future.
It has been shown that aberrant splicing of specific genes including RAN GTPase, EAAT2 and GADD45a caused by poly-PR peptide in human astrocytes contributes to the toxicity of poly-PR peptide (12) . We demonstrated that poly-PR peptide interacts with mRNA of these genes in mouse motorneuronal NSC34 cells (Fig. 6C ). However, we did not observe the alteration of splicing of these genes ( Supplementary Material, Fig. S1 ), suggesting that inhibition of protein translation rather than aberrant splicing of these genes underlies the toxicity seen in this model. It is also possible that poly-PR sequesters mRNA in both cytosol and nucleus, affecting mRNA splicing and protein translation in a celltype-dependent manner.
Although how sequestration of RNA by poly-PR/GR peptide and other RNA-binding ALS-causative genes functionally interact in the pathogenesis of ALS remains to be determined, a therapeutic strategy targeting the cell-penetrating toxic dipeptide-repeat proteins may potentially rescue the protein translation and protect neurons from the neurotoxicity in patients with C9orf72 FTD/ALS.
Materials and Methods

HA-peptide and poly-dipeptide peptide
HA peptide is purchased from Pierce (Rockford, IL, USA). HA-tagged poly-(PR) 20 , HA-tagged poly-(GR) 20 and HA-tagged poly-(GA) 20 , peptide were synthesized by Genscript (Piscataway, NJ, USA).
Cell culture
NSC34 cells were maintained in Dulbecco's Modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics.
LDH assay
NSC34 cells were plated on a 96-well plate and incubated with 10 μ of HA peptide, HA-tagged poly-(PR) 20 , HA-tagged poly-(GR) 20 or HA-tagged poly-(GA) 20 peptide for 6 h. The release of LDH were assessed by Cytotoxicity LDH detection kit (Clontech).
Antibodies and reagents
Anti-HA antibody was purchased from Genetex (Irvine, CA, USA). Anti-HA antibody-conjugated agarose beads, 1-step human in vitro protein expression kits, anti-turbo GFP antibody and turbo GFP mRNA were purchased from Pierce (Rockford, IL, USA). Anti-hnRNPA1 antibody and anti-FUS antibody were purchased from Abcam (Cambridge, MA, USA). Anti-eEF1A antibody, anti-phosphorylated eIF2A antibody, anti-eIF3A antibody, anti-eIF4A antibody, anti-eIF4A1A antibody, anti-eIF4B antibody, anti-phospho-eIF4B antibody, anti-eIF4E antibody, anti-phospho-eIF4E antibody, anti-eIF4G antibody, anti-phospho-eIF4G antibody, anti-eIF4H antibody, anti-RPL7A antibody, anti-poly (ADP-ribose) polymerase (PARP) antibody, anti-HSP70 antibody and anti-glyceraldehyde 3phosphate dehydrogenase (GAPDH) antibody were obtained from Cell signaling technology (Danvers, MA, USA). Anti-TDP43 antibody was purchased from Proteintech (Chicago, IL, USA). Yeast total RNA and ribonuclease A were obtained from Sigma (St Louis, MO, USA). Oligo-dT (25) sepharose beads were obtained from New England Biolabs (Ipswich, MA, USA). Anti-poly-GR antibody clone 5A2 were obtained from Millipore (Billerica, MA, USA).
Immunohistochemical staining
Sections of formalin-fixed paraffin embedded brain tissues were dipped with xylene to remove paraffin, then followed by hydration in an ethanol series. Then, heat-induced antigen retrieval was carried out using sodium citrate buffer ( pH 6.8) before being incubated with blocking serum. The sections were washed twice with Tris-buffered saline ( pH 7.4) containing 0.1% tween-20. The sections were then incubated with 0.5% triton X-100 for 10 min at room temperature in preparation for immunohistochemistry. The sections were incubated with primary antibodies overnight at 4°C. For the double-labeling immunofluorescence staining, fluorescein isothiocyanate -conjugated anti-rabbit IgG and Cy3 conjugated anti-rat IgG secondary antibodies were used. All slides were mounted with 4′,6-diamidino-2-phenylindole containing mounting medium (Vector Laboratories, Burlingame, CA, USA). liquid chromatography-tandem mass spectrometry/ mass spectrometry NSC34 cells plated on a 15 cm dish were cultured with 5 μ HA peptide (Pierce) or 5 μ of poly-(PR) 20 peptide for 5 days. The cells were harvested, washed with phosphate-buffered saline (PBS) and lysed in a immunoprecipitation buffer [150 m NaCl, 50 m hydroxyethyl-piperazine ethanesulfonic acid (HEPES) pH 7.4, 0.5% NP-40, 1 m ethylenediaminetetraacetic acid (EDTA) and protease inhibitor cocktail]. After centrifugation to remove cellular debris, immunoprecipitation was performed with anti-HA antibody-conjugated agarose beads (Pierce). The immunoprecipitates were analyzed with LC-MS/MS by Applied Biomics (Hayward, CA, USA).
Interactome of identified proteins
Prediction of interaction of proteins identified by LC-MS/MS was performed with the Panther software and STRING ver. 9.1 software. For STRING, the confidence score at the level of 0.7 was used to show the best fitted protein-interactive network.
Immunoprecipitation NSC34 cells were lysed in cell lysis buffer (150 m NaCl, 0.5% NP40, 50 m HEPES pH 7.4, 1 m EDTA, 1 m dithiothreitol (DTT) and protease inhibitor cocktail) followed by centrifugation at 15 000 rpm to remove cellular debris. The supernatants were incubated with 5 μg/ml HA peptide or poly(PR) 20 peptide for 2 h in the presence or absence of RNAse (100 μg/ml). Then, immunorepcipitation was performed with anti-HA antibody-conjugated agarose beads. The beads were washed four times with the lysis buffer and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis.
RNA immunoprecipitation and RT-PCR
NSC34 cells plated on a six-well plate were treated with 3 μ of HA peptide or HA-tagged poly(PR) 20 , HA-tagged poly(GR) 20 or HA-tagged poly(GA) 20 for 6 h. The cells were harvested, washed with PBS and lysed in a RIP immunoprecipitation (RIP) buffer (150 m KCl, 25 m Tris-HCl, pH 7.4, 5 m EDTA, 0.5 m DTT, 0.5% NP40, 100 U/ml RNAse inhibitor and protease inhibitor cocktail). After centrifugation to remove cellular debris, immunoprecipitation was performed with anti-HA antibody-conjugated agarose beads. RNA were isolated from the immunoprecipitates using RNeasy (Qiagen, Netherland), according to the manufacturer's instructions. The cDNA was synthesized using ImProm-II Reverse Transcription System (Promega, Madison, WI, USA). The primers used in the PCR are following: for mouse EAAT2, ACAATATGCCCAAGCAGGTAGA and CTTTGGCTCATCGGAGCTGA; for mouse Ran GTPase, CCACTTGACGGGCGAGTTT and CCACAC AATACAATGGGGATGTT; for mouse NACA, GACAGTGATGAGTCA GTACCAGA and TGCTTGGCTTTACTAACAGGTTC; for mouse Gadd45a, CCGAAAGGATGGACACGGTG and TTATCGGGGTCTACG TTGAGC.
In vitro translation
IVT was performed using 1-Step Human In Vitro Protein Expression Kit (Pierce) according to the manufacturer's instructions. Real-time monitoring of fluorescence of expressed GFP was performed with ViiA7 (Life Technologies, Carlsbad, CA, USA).
Measurement of protein translation in vivo
The rate of protein synthesis was measured by the SUnSET method. Briefly, newly synthesized protein in NSC34 cells pretreated with HA peptide or HA-poly-(PR) 20 peptide for 2 h were labeled by incubation with 2 μg/ml puromycin for 30 min. the lysates were immunoblotted with anti-puromycin antibody (Millipore, Billerica, MA, USA).
The measument of turbidity
The measurement of turbidity was performed using NanoDrop 2000 (Thermo Scientific, Waltham, MA, USA) according to the manufacturer's instructions.
Electron microscope imaging
HA-tagged poly-(PR) 20 peptide (5 μ), RNA (500 ng/μl) and a mixture of HA-tagged poly-(PR) 20 peptide and RNA were shaked at 200 rpm at room temperature for 72 h prior to imaging with an electron microscope. The samples were negatively stained with 2% uranyl acetate.
Oligo-dT pulldown
NSC34 cells cultured with 10 μ HA peptide or HA-poly-(PR) 20 peptide for 4 h were fixed with 4% paraformaldehyde and then lysed with 1% triton X-100 with syringe and 26-G needle. After centrifugation, the cell lysates were pulldowned with oligo-dT beads (New England Biolab). Briefly, the lysates were incubated with oligo-dT beads for 1 h at 4°C in a pulldown buffer (20 m Tris-HCl, pH 7.5, 0.5% lithium dodecyl sulfate, 500 m LiCl), washed twice with washing buffer (20 m Tris-HCl, pH 7.5, 0.1% lithium dodecyl sulfate, 150 m LiCl), followed by immunoblot analyses.
HSP70-binding assay
Recombinant HSP70 and HSP40 (Boston Biochem) were incubated with HA-poly-(PR) 20 peptide and 1 m adenosine triphosphate in the presence or absence of 1 mg/ml RNA or poly-rA for 1 h at 37°C. The complex was immunoprecipitated with anti-HA antibody followed by immunoblot analysis.
DSP crosslinking assay
One millimolar of HA-tagged poly-(PR) 20 , HA-tagged poly-(GR) 20 , HA-tagged poly-(GA) 20 , were mixed with 1 mg/ml of RNA or homopolymeric ribonucleotides ( poly-rA, poly-rG, poly-rC and poly-rU) and incubated for 5 min at room temperature. Then, 20 m DSP was added (final 2 m) and incubated for 30 min at 37°C, followed by Coomassie blue staining.
Reverse transcriptase-polymerase chain reaction NSC34 cells were treated with 10 μ HA-poly(PR) 20 , 10 μ HA-poly (GA) 20 or untreated for 6 or 24 h. mRNA were purified with RNeasy kit (Promega) and reverse transcribed with M-MLV reverse transcriptase (Promega). Mouse EAAT2 cDNA fragment spanning from Exon 7 to Exon 11 was amplified with primers; 5′-TGCTT GATTTGTGGGAAGATCATCG-3′ and 5′-TGCAGTCAGCTGACTTT CCATTGG-3′. Mouse RAN GTPase cDNA fragment spanning from Exon 1 to Exon 5 was amplified with primers; 5′-AGAGCCGC AGGTCCAGTTCAAG-3′ and 5′-GAGAGCAGTCGTCTGAGCAAC-3′. Mouse GADD45a cDNA fragment spanning from Exon 1 to Exon 4 was amplified with primers; 5′-ATGACTTTGGAGGAATTCT CGGC-3′ and 5′-AAGGCAGGATCCTTCCATTGTGATG-3′.
Immunocytochemistry NSC34 cells cultured with 5 μ HA peptide or HA-poly-(PR) 20 peptide for overnight were fixed with 4% paraformaldehyde for 10 min and then permeabilized with 0.2% triton X-100 for 5 min. After blocking of non-specific binding with bovine serum albumin, cells were incubated with mouse monoclonal anti-hnRNPA1 antibody (Abcam) and rabbit anti-HA antibody (Genetex). After three washes, the cells were incubated with Alexa Fluor 488-conjugated anti-mouse secondary antibody or Alexa Fluor 568-conjugated anti-rabbit secondary antibodies (Thermo Fisher) and examined with a confocal microscope (Eclipse 80i; Nikon, Tokyo, Japan).
Cell fractionation immunoprecipitation
Fractionation of cytosol and nucleus from NSC34 cells treated 5 μ HA peptide or HA-poly-(PR) 20 peptide for overnight was done by ProteoExtract Subcellular Proteome Extraction Kit (Millipore) following the manufacturer's protocol. After fractionation, immunoprecipitation using the nuclear fraction was performed with anti-HA antibody-conjugated agarose beads. The beads were washed five times with the immunoprecipitation buffer and analyzed by SDS-PAGE and immunoblot analysis.
Statistical analysis
Statistical analysis of the data was performed by one-way analysis of variance (ANOVA) followed by Dunnet's test or Student's t-test using SPSS 22 (IBM).
Study approval
Studies involving human subjects were approved by the Washington University Human Studies Committee and the Clinical Research Unit Advisory Committee (an Institute of Clinical and Translational Sciences resource unit). Written informed consent was received from all participants prior to inclusion in the study.
Patient samples
Patients samples (C9ORF72-negative patient 1; male, 70 years old, C9ORF72-negative patient 2; male, 74 years old, C9ORF72-positive patient 1; female, 65 years old, C9ORF72-positive patient 2; male, 70 years old) were obtained through appropriate consenting procedures for the collection and use of the human brain tissues. The GGGGCC hexanucleotide expansion in C9ORF72 was confirmed by repeat-primed PCR assay.
